Do-It-Yourself Guide to ODAC
Circle One: Yes, No, Maybe
FDA has often asked ODAC members to discuss broad scientific questions. However, the approval questions have, without an exception, been shoehorned into the up-or-down dichotomy.
What is ODAC without a vote on approval questions?
Here, The Cancer Letter has combined a transcript of the ODAC discussion with a coding scale that may provide a clue about how the vote on necitumumab would have gone.